MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in PGEN — Precigen, Inc.

CIK 1705339 CAUSEWAY BAY, K3

Position in PGEN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$414,503

-$26,725 QoQ

Shares Held

107,107

+1.5% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,178,526 across 240 Biotechnology names. PGEN ranks #126 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	171,925	$76,771,388
2	REGN	Regeneron Pharmaceuticals, Inc.	69,854	$53,971,993
3	ALNY	Alnylam Pharmaceuticals, Inc.	81,325	$26,908,001
4	INSM	INSMED Inc	122,958	$20,106,091
5	RPRX	Royalty Pharma plc	419,129	$20,105,617
6	PRAX	Praxis Precision Medicines, Inc.	27,744	$8,938,838
7	ARWR	Arrowhead Pharmaceuticals, Inc.	139,598	$8,752,793
8	MRNA	Moderna, Inc.	147,589	$7,497,520

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$414,503	107,107	+1.5%	Shares	Defined	2026-05-15
2025-12-31	$441,228	105,557	+42.1%	Shares	Defined	2026-02-17
2025-09-30	$244,321	74,262	-9.5%	Shares	Defined	2025-11-14
2025-06-30	$116,560	82,085	+0.6%	Shares	Defined	2025-08-14
2025-03-31	$121,598	81,610	+12.5%	Shares	Defined	2025-05-15
2024-12-31	$81,275	72,567	+4.7%	Shares	Defined	2025-02-14
2024-09-30	$65,831	69,296	+3.9%	Shares	Defined	2024-11-14
2024-06-30	$105,397	66,707	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.